Category: Intuitive Surgical Inc.
Robot-assisted surgical devices maker Intuitive Surgical takes offense as doctors at a major U.S. cancer center warn that robot-assisted surgery may have little to offer patients undergoing surgical bladder removal.
The much-disputed field of robot-assisted surgery took another blow this week when doctors from Memorial Sloan Kettering Cancer Center warned that the high-tech procedure may be no better than traditional surgery for patients with invasive bladder cancer.
Troubled Intuitive Surgical manages to blow away Wall Street's expectations, even as Q2 profits drop 35% year-over-year.
California device maker Intuitive Surgical (NSDQ:ISRG) got a major after-hours boost after reporting Q2 numbers that, while still down year-over-year, beat Wall Street's expectations by a mile.
Researchers say that robot-assisted surgery is as good as open surgery in controlling prostate cancer for 10 years.
Robot-assisted radical prostatectomy (RARP) proved just as good as open surgery in keeping the prostate cancer under control for 10 years following the procedure, according to a new study from researchers at the Henry Ford Hospital.
Nearly 99% of the RARP patients enrolled in the study survived cancer for a decade following surgery and about 73% were recurrence-free and 97.5% of the group was metastasis-free, according to the report.
A federal appeals court upholds a lower court's decision to dismiss a shareholders lawsuit accusing Intuitive Surgical and its management of misleading investors.
Researchers use Intuitive Surgical's da Vinci robotic surgery system as a cautionary tale about the rapid adoption of new technologies that require physician training.
Intuitive Surgical says it's shifting from distribution to direct sales for its da Vinci surgical robot in Japan.